Andrea Chicca is the founder of Synendos Therapeutics. Synendos Therapeutics has raised $31M in total funding. Latest round: Series A.
Andrea Chicca is the Co-founder and CEO of Synendos Therapeutics, a clinical-stage neuroscience company based in Basel, Switzerland. He founded the company in April 2019 and led it to secure CHF 20 million in Series A funding, later extended to CHF 24 million.
Full founder directory · Investor directory · Company funding database · Fundraising library